The following HTML text is provided to enhance online
readability. Many aspects of typography translate only awkwardly to HTML.
Please use the page image
as the authoritative form to ensure accuracy.
Informed decision making and prostate cancer screening
Survey of knowledge, attitudes, and anticipated practices of physicians in training regarding prostate cancer screening
Clarifying the treatment decision process and post-treatment quality of life factors among prostate cancer survivors
Prostate cancer treatment and quality of life among minority populations with prostate cancer
Colorectal Cancer
Increasing participation in colorectal cancer screening
Barriers to participant's compliance in a flexible sigmoidoscopy screening program
Compliance barriers to free-of-charge colorectal flexible sigmoidoscopy screening services in populations 60 to 64 years of age
Proposal to develop and evaluate a colorectal cancer screening measure for Health Plan Employer Data and Information Set (HEDIS)
Community assessments of the burden of colorectal cancer
SOURCE: Kevin Brady, Acting Deputy Director, Division of Cancer Prevention and Control, National Center for Chronic Disease Prevention and Health, CDC, personal communication to Maria Hewitt, March, 1999.
Other cancer-related health services research is conducted within other areas of CDC. Two projects were identified within the Epidemiology Program Office: Mammography utilization in an HMO, and treatment issues related to breast and cervical cancer. Within the National Center for Health Statistics, researchers are evaluating the role of social class and race/ethnicity on the incidence of cancer (HSRProj, 1998).
Department of Defense
Beginning in FY 1992, the U.S. Congress directed the Department of Defense (DoD) to manage several appropriations for an extramural grant program directed toward specific research initiatives. The United States Army Medical Research and Materiel Command (USAMRMC) constituted the office of the Congressionally Directed Medical Research Programs (CDMRP) to administer these funds. To date, between FY 1992 and 1999, $1.1 billion has been targeted by Congress for research on breast cancer, prostate cancer, ovarian cancer, neurofibromatosis, defense women's health, and osteoporosis. The CDMRP strives to identify gaps in funding and provide award opportunities that will enhance program research objectives without duplicating existing funding opportunities.
The three DoD programs targeted at cancer research include the following:
Breast cancer: Between FY 1992 and 1999, $883.8 million has been appropriated to the Breast Cancer Research Program (BCRP). Proposals are sought across all areas of laboratory, clinical, behavioral, and epidemiological research including all disciplines within the basic, clini-
